173 related articles for article (PubMed ID: 35265825)
1. Bone mineral: A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin.
Liu Y; Nadeem A; Sebastian S; Olsson MA; Wai SN; Styring E; Engellau J; Isaksson H; Tägil M; Lidgren L; Raina DB
Mater Today Bio; 2022 Mar; 14():100227. PubMed ID: 35265825
[TBL] [Abstract][Full Text] [Related]
2. Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma.
Liu Y; Raina DB; Sebastian S; Nagesh H; Isaksson H; Engellau J; Lidgren L; Tägil M
Acta Biomater; 2021 Sep; 131():555-571. PubMed ID: 34271171
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal
Liu Y; Sebastian S; Huang J; Corbascio T; Engellau J; Lidgren L; Tägil M; Raina DB
Front Bioeng Biotechnol; 2022; 10():1076320. PubMed ID: 36601389
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin.
Xiong H; Du S; Ni J; Zhou J; Yao J
Biomaterials; 2016 Jul; 94():70-83. PubMed ID: 27105438
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
[TBL] [Abstract][Full Text] [Related]
6. Hybrid nanofibers based on poly-caprolactone/gelatin/hydroxyapatite nanoparticles-loaded Doxycycline: Effective anti-tumoral and antibacterial activity.
Ramírez-Agudelo R; Scheuermann K; Gala-García A; Monteiro APF; Pinzón-García AD; Cortés ME; Sinisterra RD
Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():25-34. PubMed ID: 29208285
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyapatite-binding albumin nanoclusters for enhancing bone tumor chemotherapy.
Kang NW; Lee JY; Kim DD
J Control Release; 2022 Feb; 342():111-121. PubMed ID: 34990700
[TBL] [Abstract][Full Text] [Related]
8. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effects of Zoledronic Acid-Loaded Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticles on Osteosarcoma.
Xu Y; Qi J; Sun W; Zhong W; Wu H
Front Bioeng Biotechnol; 2022; 10():897641. PubMed ID: 35694235
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells.
Niu G; Yousefi B; Qujeq D; Marjani A; Asadi J; Wang Z; Mir SM
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111554. PubMed ID: 33321618
[TBL] [Abstract][Full Text] [Related]
11. Loading and Releasing Behavior of Selenium and Doxorubicin Hydrochloride in Hydroxyapatite with Different Morphologies.
Gao J; Huang J; Shi R; Wei J; Lei X; Dou Y; Li Y; Zuo Y; Li J
ACS Omega; 2021 Mar; 6(12):8365-8375. PubMed ID: 33817497
[TBL] [Abstract][Full Text] [Related]
12. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
[TBL] [
